| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | Australia | 2 | |
| #4 | Canada | 2 | |
| #5 | Israel | 2 | |
| #6 | Singapore | 2 | |
| #7 | Hungary | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Serbia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds | |
| #4 | Peptides | |
| #5 | Special acyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Coric Vladimir | 14 |
| #2 | Berman Robert | 8 |
| #3 | Qureshi Irfan | 6 |
| #4 | Reitz Allen B | 4 |
| #5 | Saleh Amgad | 3 |
| #6 | Yu Danny | 3 |
| #7 | Smith Garry Robert | 2 |
| #8 | Wrobel Jay Edward | 2 |
| #9 | Bian Haiyan | 2 |
| #10 | Remeur Camille | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021072140A1 | Prodrugs of myeloperoxidase inhibitors | |
| WO2021035101A1 | Molecules that bind to tdp-43 for the treatment of amyotrophic lateral sclerosis and related disorders | |
| WO2020037152A1 | Use of riluzole oral disintigrating tablets for treating diseases | |
| KR20210034621A | Uses of riluzole prodrugs for the treatment of Alzheimer's disease |